Slide 1: Delivering world-first products and innovation in the cardiac & medtech sectors
ly =hydrix sonal use o { Delivering world- 3 first products & > innovation in the 5 cardiac & medtech sectors
Slide 2: Hydrix: technology innovation company with vision to improve a billion lives
hydrix ventures Client Venture Investments A technology innovation company with; vision to impro a billion lives pture n value from uity minority ment in high- Fee for Service Product Development Building on a rich 20-year history in breakthrough cardiac & medtech product development medical Distrib
Slide 3: Cardiovascular disease - the world's leading cause of death
hydrix = 5 Cardiovascular disease - ’ ° q the world’s leading cause of death 12) > neon . . — Asignificant Group focus on improving management of (© cardiovascular disease creates synergistic point of difference Cc 2 Global chronic health disease, aging population, strong tailwinds v= + = 32% of all
Slide 4: For personal use only
For personal use only • • • • • • •
Slide 5: Investing in early-stage high potential medtech clients
hydrix ventures m., < Investing in early-stage high 1 ry fs) , ; f 1 o potential medtech clients = capturing more of the value we create beyond Fee-for-Services | u \ THEIR ? ANNOUNCED jh , Oo. Project-to-Investment size ~3x-5x, 3-5 years to commencing sales, target 5x-10x cash multiple return ONES
Slide 6: For personal use only
For personal use only • • • • • • • • •
Slide 7: For personal use only
For personal use only • • • • • • • • • • • •
Slide 8: FY23 highlights: revenue growth, profitability and NTA increase
hydrix + $13.2m revenues was 28% YoY increase + Profitable each quarter and for the full year ($0.39) + Improved billable utilisation & contract pricing For personal use only 8 | Hydrix Commercial in confidence hydrix ventures + Three maturing assets, major valuation inflection points + Net Tangible
Slide 9: For personal use only
For personal use only • • • • • • • • • •
Slide 10: Corporate snapshot - strong insider support
hydrix Corporate snapshot — strong insider support Major Shareholders National Nominees Towns Corporation Top 20 Board Gavin Coote (GAICD) Julie King (GAICD) For personal use only Paul Lewis (FAICD) Paul Wright Joanne Bryant Alyn Tai John W. King & related entities Paul Lewis & related entities Puse
Slide 11: For personal use only
For personal use only
Slide 12: Hydrix Services - strong growth, profitability ahead
Hydrix Services — strong growth, profitability ahead Driving growth in International markets 2 Hydrix Services EBITDA (Segment Only)* Hydrix Services Revenue (Segment Only) [e) Dec-20 Jun-21 Dec-21 Jun-22-Dec-22— Jun-23 Dec-20 © Jun-21. Dec-21.— Jun-22,-Dec-22.Jun-23 4g 92.00 yp 97.00 oO : g n = $05
Slide 13: For personal use only
For personal use only • • • • • • • • • • • • • • • • • • • •
Slide 14: The Guardian - Regulatory approvals and medical reimbursement
The GUARDIAN - Regulatory approvals and medical reimbursement Hydrix is actively working on regulatory approvals and reimbursement processes across multiple jurisdictions, and other market Countr USA/ FDA Singapore / HSA Malaysia / Ministry of Health Thailand /Thai FDA Hong Kong Japan Australia / TG
Slide 15: Hydrix Limited - Board of Directors
For personal use only Hydrix Limited - Board of Directors Mr Gavin Coote Executive Chairman Gavin has extensive execut and board leadership experience, gained in the SA and Australia, working at companies with revenues of to $1 billion across diverse industries. It includes years with icewaterhouseC
Slide 16: Hydrix - Senior Leadership
Hydrix — Senior Leadership PP Paul Kelly General Manager Hydrix Medical Paul has 35+ years of international medical device distribution and services leadership with ‘companies including Getz, Medtronic, Baxter Healthcare and CardioScan. With an impressive track record in implantable and non-invasive
Slide 17: Hydrix - Senior Leadership (cont'd)
Hydrix — Senior Leadership (cont'd) Michael Trieu General Manager Hydrix Services Michael is an R&D innovation leader with 20 years of hands-on system innovation research, design development and delivery experience in the field of military underwater sonar, active implantable medical devices, contro
Slide 18: Disclaimer
For personal use only hydrix Disclaimer This presentation has been prepared by Hydrix Limited {the "Company" or “Hydrix"). This presentation is being provided to investors for the sole purpose of providing preliminary background financial and other information to enable recipients to review the busi
Slide 19: For more information, please visit www.hydrix.com
hydrix For more information, please visit: www.hydrix.com